Diseases, Conditions, Syndromes

SGLT2i use linked to reduced risk for flare in adults with gout, T2D

For patients with gout and type 2 diabetes, sodium-glucose cotransporter-2 inhibitors (SGLT2is) are associated with a reduced risk for recurrent gout flares and gout-primary emergency department visits and hospitalizations, ...

page 2 from 40